• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

ProShares Ultra Nasdaq Biotechnology

+ Add to Watchlist

BIB:US

121.3700 USD 4.7200 4.05%

As of 20:10:00 ET on 10/30/2014.

Snapshot for ProShares Ultra Nasdaq Biotechnology (BIB)

Open: 116.5000 High - Low: 121.7500 - 115.6000 Primary Exchange: NASDAQ GM
Volume: 293,029 52-Week Range: 57.3005 - 121.7500 Beta vs NBI: 1.6855

ETF Chart for BIB

No chart data available.
  • BIB:US 121.3700
  • 1D
  • 1M
  • 1Y
116.6500
Interactive BIB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BIB

ProShares Ultra Nasdaq Biotechnology is an an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to twice (200%) the return of the Nasdaq Biotechnology Index.

Inception Date: 2010-04-08 Telephone: 1-240-497-6400
Managers: HOWARD S RUBIN
Web Site: www.proshares.com

Fundamentals for BIB

NAV (on 2014-10-30) 121.3300
Assets (M) (on 2014-10-30) 424.6577
Shares out (M) 3.50
Market Cap (M) 424.80
% Premium 0.03
Average 52-Week % Premium 0.0059
Fund Leveraged Y
Fund Leverage Percent 200.0000 %

Dividends for BIB

Dividend Type Discontinued
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -%

Performance for BIB

1-Month +16.72% 1-Year +92.02%
3-Month +30.94% 3-Year +95.45%
Year To Date +61.30% 5-Year -
Expense Ratio 0.95

Top Fund Holdings for BIB

Filing Date: 09/30/2014
Name Position Value % of Total
Amgen Inc 135,104 18,976,708 8.286%
Celgene Corp 198,177 18,783,216 8.201%
Gilead Sciences Inc 175,040 18,633,008 8.136%
Biogen Idec Inc 54,894 18,159,484 7.929%
Regeneron Pharmaceuticals Inc 46,708 16,839,168 7.352%
Vertex Pharmaceuticals Inc 100,624 11,301,081 4.934%
Alexion Pharmaceuticals Inc 55,617 9,222,411 4.027%
Mylan Inc/PA 192,724 8,767,015 3.828%
Illumina Inc 52,494 8,604,816 3.757%
BioMarin Pharmaceutical Inc 75,800 5,469,728 2.388%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil